Pakistan · Delayed Price · Currency is PKR Theseus Pharmaceuticals Statistics
Total Valuation
PSX:PMRS has a market cap or net worth of PKR 1.22 billion. The enterprise value is 30.93 billion.
| Market Cap | 1.22B |
| Enterprise Value | 30.93B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PSX:PMRS has 3.75 million shares outstanding.
| Current Share Class | 3.75M |
| Shares Outstanding | 3.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.07% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| PB Ratio | 0.09 |
| P/TBV Ratio | 0.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.26 |
| EV / Sales | 0.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.72.
| Current Ratio | 0.74 |
| Quick Ratio | 0.14 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.67 |
Financial Efficiency
Return on equity (ROE) is -30.14% and return on invested capital (ROIC) is -4.53%.
| Return on Equity (ROE) | -30.14% |
| Return on Assets (ROA) | -3.70% |
| Return on Invested Capital (ROIC) | -4.53% |
| Return on Capital Employed (ROCE) | -14.88% |
| Revenue Per Employee | 24.94M |
| Profits Per Employee | -1.66M |
| Employee Count | 1,401 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.19 |
Taxes
| Income Tax | -2.61B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.23% in the last 52 weeks. The beta is -0.07, so PSX:PMRS's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -29.23% |
| 50-Day Moving Average | 290.68 |
| 200-Day Moving Average | 437.81 |
| Relative Strength Index (RSI) | 61.71 |
| Average Volume (20 Days) | 990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PSX:PMRS had revenue of PKR 34.94 billion and -2.33 billion in losses.
| Revenue | 34.94B |
| Gross Profit | -114.95M |
| Operating Income | -2.84B |
| Pretax Income | -6.97B |
| Net Income | -2.33B |
| EBITDA | -557.10M |
| EBIT | -2.84B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.39 billion in cash and 24.26 billion in debt, giving a net cash position of -22.87 billion or -6,099.97 per share.
| Cash & Cash Equivalents | 1.39B |
| Total Debt | 24.26B |
| Net Cash | -22.87B |
| Net Cash Per Share | -6,099.97 |
| Equity (Book Value) | 14.08B |
| Book Value Per Share | n/a |
| Working Capital | -7.16B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -0.33%, with operating and profit margins of -8.12% and -6.68%.
| Gross Margin | -0.33% |
| Operating Margin | -8.12% |
| Pretax Margin | -19.96% |
| Profit Margin | -6.68% |
| EBITDA Margin | -1.59% |
| EBIT Margin | -8.12% |
| FCF Margin | n/a |
Dividends & Yields
PSX:PMRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -191.98% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |